Astera Labs (ALAB) COO awarded 26,522 RSUs and reports major shareholdings

Rhea-AI Filing Summary

Astera Labs, Inc. insider filing shows new equity compensation for a senior executive. President and COO, and director, Gajendra Sanjay received 26,522 restricted stock units (RSUs) of common stock on February 6, 2026 at a stated price of $0.

The RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on his continued service. Following this award, he directly beneficially owns 1,626,272 common shares. Additional common shares are held through three separate estate-planning trusts, where he disclaims beneficial ownership except for any pecuniary interest.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Gajendra Sanjay

Role President and COO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	26,522	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,626,272 shares (Direct); Common Stock — 5,864,213 shares (Indirect, By Trust 1)

Footnotes (1)

1. These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gajendra Sanjay

(Last) (First) (Middle)

C/O ASTERA LABS, INC.

2345 NORTH FIRST STREET

(Street)

SAN JOSE CA 95131

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		A		26,522(1)	A	$0	1,626,272	D
Common Stock								5,864,213	I	By Trust 1(2)
Common Stock								695,000	I	By Trust 2(3)
Common Stock								695,000	I	By Trust 3(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

2. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

3. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Remarks:

	/s/ Philip Mazzara, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the latest Astera Labs (ALAB) Form 4 filing show?

The Form 4 shows Astera Labs President and COO Gajendra Sanjay received 26,522 restricted stock units on February 6, 2026. It also reports his direct holdings of 1,626,272 common shares plus additional shares held through three separate estate-planning trusts.

How many RSUs did Astera Labs executive Gajendra Sanjay receive?

Gajendra Sanjay received 26,522 restricted stock units of Astera Labs common stock. Each RSU represents a contingent right to one share, subject to vesting conditions tied to his continued service with Astera Labs over a multi-year vesting schedule.

What is the vesting schedule for the new Astera Labs RSU grant?

The RSU award vests 25% on February 15, 2027. The remaining 75% vests in 12 equal quarterly installments thereafter, provided Gajendra Sanjay maintains a continuous service relationship with Astera Labs through each applicable vesting date.

How many Astera Labs shares does Gajendra Sanjay own directly after this grant?

After the reported RSU grant, Gajendra Sanjay beneficially owns 1,626,272 Astera Labs common shares directly. This figure reflects his direct holdings only and is separate from additional shares held through various estate-planning trusts noted in the Form 4.

What are the Astera Labs shares held through estate-planning trusts?

The filing lists 5,864,213 common shares held by Trust 1, 695,000 by Trust 2, and 695,000 by Trust 3. These are estate-planning trusts, and Gajendra Sanjay disclaims beneficial ownership, except to the extent of any pecuniary interest he may have.

Does Gajendra Sanjay claim full beneficial ownership of the trust-held Astera Labs shares?

No. For Trusts 1, 2, and 3, he disclaims beneficial ownership of the Astera Labs shares, except to the extent of any pecuniary interest. The filing states it is not an admission that he is the beneficial owner for Section 16 purposes.

What roles does Gajendra Sanjay hold at Astera Labs (ALAB)?

According to the filing, Gajendra Sanjay serves as both a director and as President and Chief Operating Officer of Astera Labs. His dual role underscores his leadership position and explains why his equity awards and holdings are reported in a Form 4.